Scot C. Remick
Publications by Year
Research Areas
Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment, Cancer Treatment and Pharmacology, Chronic Lymphocytic Leukemia Research, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data(1999)892 cited
- → Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors(2010)406 cited
- A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.(2002)
- → Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment(2011)313 cited
- → Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma(2009)256 cited
- → Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid(2012)214 cited
- → Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) Results of Protocol E1293(1996)196 cited
- → Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients(2013)185 cited
- → A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome(2009)182 cited
- → Extrapulmonary Small-Cell Carcinoma(1987)177 cited